V Square Quantitative Management LLC Acquires 2,243 Shares of Nutrien Ltd. (NYSE:NTR)

V Square Quantitative Management LLC increased its holdings in Nutrien Ltd. (NYSE:NTRFree Report) by 28.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 10,115 shares of the company’s stock after buying an additional 2,243 shares during the period. V Square Quantitative Management LLC’s holdings in Nutrien were worth $453,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently modified their holdings of NTR. HHM Wealth Advisors LLC lifted its stake in Nutrien by 331.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 625 shares of the company’s stock valued at $28,000 after purchasing an additional 480 shares during the last quarter. Exchange Traded Concepts LLC lifted its stake in Nutrien by 96.7% in the fourth quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock valued at $38,000 after purchasing an additional 416 shares during the last quarter. Union Bancaire Privee UBP SA purchased a new position in Nutrien in the fourth quarter valued at approximately $67,000. Larson Financial Group LLC lifted its stake in Nutrien by 1,370.6% in the third quarter. Larson Financial Group LLC now owns 1,603 shares of the company’s stock valued at $77,000 after purchasing an additional 1,494 shares during the last quarter. Finally, Cromwell Holdings LLC lifted its stake in Nutrien by 113.4% in the third quarter. Cromwell Holdings LLC now owns 1,694 shares of the company’s stock valued at $82,000 after purchasing an additional 900 shares during the last quarter. 63.10% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Scotiabank upped their price objective on Nutrien from $59.00 to $60.00 and gave the company a “sector outperform” rating in a research note on Monday, February 10th. Barclays reiterated an “equal weight” rating and issued a $56.00 price objective (up previously from $55.00) on shares of Nutrien in a research note on Tuesday, January 21st. CIBC restated an “outperformer” rating and set a $55.00 target price (down previously from $60.00) on shares of Nutrien in a research report on Tuesday, December 10th. Oppenheimer assumed coverage on Nutrien in a research report on Thursday, December 12th. They set an “outperform” rating and a $60.00 target price on the stock. Finally, TD Securities dropped their target price on Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a research report on Tuesday, November 12th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $59.00.

Get Our Latest Research Report on NTR

Nutrien Stock Up 0.4 %

Shares of NYSE NTR opened at $50.92 on Friday. Nutrien Ltd. has a 12 month low of $43.69 and a 12 month high of $60.87. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $25.01 billion, a price-to-earnings ratio of 34.18, a PEG ratio of 1.13 and a beta of 0.81. The business has a 50-day moving average of $49.02 and a 200-day moving average of $48.14.

Nutrien Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Read More

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.